New York State Teachers Retirement System boosted its position in shares of Cantel Medical Corp. (NYSE:CMN) by 12.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 42,924 shares of the company’s stock after buying an additional 4,600 shares during the period. New York State Teachers Retirement System’s holdings in Cantel Medical Corp. were worth $2,950,000 as of its most recent SEC filing.
Several other hedge funds have also recently bought and sold shares of CMN. LS Investment Advisors LLC raised its stake in Cantel Medical Corp. by 7.5% in the second quarter. LS Investment Advisors LLC now owns 1,510 shares of the company’s stock worth $104,000 after buying an additional 106 shares in the last quarter. BlackRock Inc. raised its stake in Cantel Medical Corp. by 119.5% in the first quarter. BlackRock Inc. now owns 2,355 shares of the company’s stock worth $168,000 after buying an additional 1,282 shares in the last quarter. Cypress Wealth Advisors LLC purchased a new stake in Cantel Medical Corp. during the first quarter worth about $210,000. Mariner Wealth Advisors LLC purchased a new stake in Cantel Medical Corp. during the first quarter worth about $216,000. Finally, Bogle Investment Management L P DE purchased a new stake in Cantel Medical Corp. during the first quarter worth about $228,000. Institutional investors own 81.60% of the company’s stock.
Shares of Cantel Medical Corp. (NYSE:CMN) traded up 0.30% during mid-day trading on Wednesday, hitting $76.88. 118,110 shares of the company were exchanged. The stock’s 50-day moving average price is $77.54 and its 200 day moving average price is $71.14. Cantel Medical Corp. has a 12-month low of $53.64 and a 12-month high of $81.63. The stock has a market cap of $3.18 billion, a PE ratio of 53.46 and a beta of 1.59.
Cantel Medical Corp. (NYSE:CMN) last released its earnings results on Thursday, September 29th. The company reported $0.48 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.37 by $0.11. Cantel Medical Corp. had a return on equity of 16.70% and a net margin of 9.02%. The company had revenue of $179 million for the quarter. During the same period last year, the firm earned $0.39 EPS. The company’s revenue was up 18.3% compared to the same quarter last year. On average, equities analysts anticipate that Cantel Medical Corp. will post $1.98 EPS for the current fiscal year.
A number of analysts have recently issued reports on the stock. Needham & Company LLC assumed coverage on shares of Cantel Medical Corp. in a research note on Wednesday, August 24th. They set a “hold” rating on the stock. Benchmark Co. assumed coverage on shares of Cantel Medical Corp. in a research note on Monday, August 29th. They set a “buy” rating and a $83.00 price objective on the stock.
In other Cantel Medical Corp. news, Chairman Charles M. Diker sold 14,897 shares of Cantel Medical Corp. stock in a transaction dated Monday, October 10th. The stock was sold at an average price of $78.76, for a total transaction of $1,173,287.72. Following the transaction, the chairman now owns 3,190,111 shares of the company’s stock, valued at approximately $251,253,142.36. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Ann E. Berman sold 1,453 shares of Cantel Medical Corp. stock in a transaction dated Friday, September 30th. The shares were sold at an average price of $77.56, for a total value of $112,694.68. Following the transaction, the director now directly owns 5,424 shares in the company, valued at approximately $420,685.44. The disclosure for this sale can be found here. Company insiders own 15.30% of the company’s stock.
About Cantel Medical Corp.
Cantel Medical Corp. is a provider of infection prevention and control products and services in the healthcare market. The Company’s segments include Endoscopy, Water Purification and Filtration, Healthcare Disposables, Dialysis and Specialty Packaging. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.